Pill Identifier App

AHI M22 (Methyldopa 250 mg)

Pill imprint AHI M22 has been identified as Methyldopa 250 mg.

Methyldopa is used in the treatment of high blood pressure; hypertensive emergency and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy. Methyldopa 250 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for AHI M22

Methyldopa
Imprint:
AHI
M22
Strength:
250 mg
Color:
Peach
Shape:
Round
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, centrally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Accord Healthcare, Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)